Moderna

In: Finance

Maddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) and Mitsubishi Tanabe Pharma to co-promote Moderna’s mRNA respiratory vaccine portfolio in Japan, including Moderna’s COVID-19 vaccine, Spikevax, the companies said on Sunday. Under the joint venture agreement, Moderna (MRNA) will handle the manufacturing, sales, medical education and distribution of its mRNA respiratory vaccines.Continue Reading

In: Finance

hapabapa Moderna (NASDAQ:MRNA) on Tuesday announced a $176M contract from the U.S. government to accelerate the development of messenger-RNA-based vaccines targeting several influenza strains, including the bird flu family of viruses. The company said that the funding channeled through the Biomedical Advanced Research and Development Authority (BARDA) is expected toContinue Reading

In: Finance

rafal_olechowski Carisma Therapeutics (NASDAQ:CARM) climbed ~29% premarket Friday after the cell therapy developer said it would receive $2M for discovering a cancer drug candidate as part of a collaboration with Moderna (NASDAQ:MRNA). Nominating the first development candidate under the partnership, the company said that the unnamed drug targets Glypican-3, aContinue Reading

In: Finance

Maddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed mRESVIA, its vaccine targeted at the respiratory syncytial virus (RSV). Issuing a so-called positive opinion, EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended grantingContinue Reading